Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Ocuphire Pharma Q2 EPS $(0.52) Down From $(0.43) YoY

Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.
byBill Haddad
August 12, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Recap: Carlisle Companies Q3 Earnings

By Benzinga Insights
Today, 4:05 AM
Carlisle Companies (NYSE:CSL) reported its Q3 earnings results on Thursday, October 21, 2021 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Carlisle Companies beat their estimated earnings by 8.73%, which did not surprise analysts.

CSL